Enterococcus faecalis is both a common commensal of the human gastrointestinal tract and a leading cause of hospital-acquired infections 1 . Systemic infections with multidrug-resistant enterococci occur subsequent to gastrointestinal colonization 2 . Preventing colonization by multidrug-resistant E. faecalis could therefore be a valuable approach towards limiting infection. However, little is known about the mechanisms E. faecalis uses to colonize and compete for stable gastrointestinal niches. Pheromone-responsive conjugative plasmids encoding bacteriocins are common among enterococcal strains 3 and could modulate niche competition among enterococci or between enterococci and the intestinal microbiota. We developed a model of colonization of the mouse gut with E. faecalis, without disrupting the microbiota, to evaluate the role of the conjugative plasmid pPD1 expressing bacteriocin 21 (ref. 4) in enterococcal colonization. Here we show that E. faecalis harbouring pPD1 replaces indigenous enterococci and outcompetes E. faecalis lacking pPD1. Furthermore, in the intestine, pPD1 is transferred to other E. faecalis strains by conjugation, enhancing their survival. Colonization with an E. faecalis strain carrying a conjugationdefective pPD1 mutant subsequently resulted in clearance of vancomycin-resistant enterococci, without plasmid transfer. Therefore, bacteriocin expression by commensal bacteria can influence niche competition in the gastrointestinal tract, and bacteriocins, delivered by commensals that occupy a precise intestinal bacterial niche, may be an effective therapeutic approach to specifically eliminate intestinal colonization by multidrug-resistant bacteria, without profound disruption of the indigenous microbiota.
Enterococcus faecalis is both a common commensal of the human gastrointestinal tract and a leading cause of hospital-acquired infections 1 . Systemic infections with multidrug-resistant enterococci occur subsequent to gastrointestinal colonization 2 . Preventing colonization by multidrug-resistant E. faecalis could therefore be a valuable approach towards limiting infection. However, little is known about the mechanisms E. faecalis uses to colonize and compete for stable gastrointestinal niches. Pheromone-responsive conjugative plasmids encoding bacteriocins are common among enterococcal strains 3 and could modulate niche competition among enterococci or between enterococci and the intestinal microbiota. We developed a model of colonization of the mouse gut with E. faecalis, without disrupting the microbiota, to evaluate the role of the conjugative plasmid pPD1 expressing bacteriocin 21 (ref. 4) in enterococcal colonization. Here we show that E. faecalis harbouring pPD1 replaces indigenous enterococci and outcompetes E. faecalis lacking pPD1. Furthermore, in the intestine, pPD1 is transferred to other E. faecalis strains by conjugation, enhancing their survival. Colonization with an E. faecalis strain carrying a conjugationdefective pPD1 mutant subsequently resulted in clearance of vancomycin-resistant enterococci, without plasmid transfer. Therefore, bacteriocin expression by commensal bacteria can influence niche competition in the gastrointestinal tract, and bacteriocins, delivered by commensals that occupy a precise intestinal bacterial niche, may be an effective therapeutic approach to specifically eliminate intestinal colonization by multidrug-resistant bacteria, without profound disruption of the indigenous microbiota.
The mammalian host is colonized by 10-100 trillion microbes that live in a predominantly symbiotic relationship with their host 5, 6 . Invasion by some of these symbionts can cause serious disease when homeostasis is disrupted 7 . One such symbiont is E. faecalis, a Grampositive member of the gut microbiota of a wide range of mammals, including humans 8 . Although enterococci are usually not pathogenic, they can cause significant disease in immune-compromised individuals. Treating enterococcal infections is challenging owing to their intrinsic and acquired resistance to a wide range of antibiotics 9, 10 . Prior antibiotic therapy is a well-known risk factor for enterococcal infection 9, 11 . Antibiotic disruption of the intestinal biota enables resistant enterococci to proliferate profusely in the gastrointestinal tract 12 and invade the host 11 . Reducing colonization of the gastrointestinal tract by antibiotic-resistant enterococci could therefore represent a promising approach for preventing enterococcal infections. However, our mechanistic understanding of enterococcal gastrointestinal colonization is limited. Most previous studies employed antibiotic disruption of the intestinal microbiota before enterococcal challenge, resulting in invasion rather than colonization. Our model establishes long-term colonization of mice with a marked strain of E. faecalis without antibiotic pretreatment, allowing us to study E. faecalis dynamics in an unperturbed intestinal environment.
We established long-term colonization of FVB mice by prolonged feeding with a rifampicin-resistant E. faecalis strain (EF r ), CK135. After withdrawal of EF r from the drinking water, mice maintained persistent colonization of the gastrointestinal tract and shedding of EF r in faeces for more than eleven weeks (data shown for first four weeks, Fig. 1a, b ). In contrast, mice gavaged with ,10 9 colonyforming units (CFU) of EF r demonstrated short-lived colonization (2-3 days), with significant mouse-to-mouse variability. Although the specific factors that determine bacterial gastrointestinal colonization fitness are unclear, the success of our model depends on both the nature and the route of delivery and offers a means of investigating the underlying mechanisms. Similar levels and patterns of EF r colonization were observed in C57Bl/6 mice and with multiple lineages of E. faecalis (Extended Data Fig. 1a, b ), suggesting that this approach for mouse gastrointestinal colonization by E. faecalis is generalizable.
We sought to understand the effect of bacteriocins-antimicrobial peptides often encoded on pheromone-responsive plasmids-on enterococcal colonization dynamics of the gastrointestinal tract. Bacteriocin production is a tool bacteria can use to enhance the stability of their communities 13 , by outcompeting closely related bacterial species and establishing a stable niche for the producing strain 14, 15 . Many lactic acid bacteria produce bacteriocins [15] [16] [17] [18] . The enterococcal bacteriocin, bacteriocin 21 (bac-21), is encoded on the sex-pheromone-responsive conjugative plasmid pPD1 (ref. 19) and is identical in nucleotide sequence to another well-characterized enterococcal bacteriocin, (Supplementary Table 1a , b). The prevalence of pPD1, first isolated from an enterococcal strain of human gingival origin, has not been described. Only the pheromone-responsive and bacteriocin operons (bac) of pPD1 have previously been sequenced 4, 19 . Complete sequencing and annotation of pPD1 revealed a 57,732-base-pair (bp) plasmid with a total of 59 open reading frames (ORFs) (Extended Data Fig. 2 and Supplementary  Table 2 ). The pPD1 bac operon contains nine genes, designated from bacA to bacI 19 , of which bacA encodes a 105-amino-acid precursor of bac- 21 (ref. 19) . The genes bacB to bacI are thought to be involved in processing, modification and secretion of the mature 70-amino-acid bacteriocin and providing immunity to the bacteriocin producer 19 .
Colonization experiments with an E. faecalis strain harbouring pPD1 (EF r 1 pPD1) revealed that EF r 1 pPD1 was significantly more abundant than EF r in faeces and throughout the gastrointestinal tract, suggesting more effective colonization ( Fig. 1a, b ). To test whether pPD1-encoded bac-21 drives enhanced enterococcal colonization, we introduced an in-frame deletion of bacAB into pPD1 (EF r 1 pPD1::DbacAB). EF r 1 pPD1::DbacAB did not exhibit a growth defect in vitro and lacked bacteriocin activity (Extended Data Fig. 3a ). Mice were colonized with EF r 1 pPD1, EF r 1 pPD1::DbacAB or EF r . EF r 1 pPD1::DbacAB showed no colonization advantage over EF r and demonstrated impaired long-term persistence in the gastrointestinal tract compared to EF r 1 pPD1 and EF r (Fig. 1c, d) , possibly owing to the excessive burden of maintaining a large non-functional plasmid. Alternatively, it is possible that unknown colonization factors expressed in the presence of an intact pPD1 are affected by bacAB deletion, resulting in loss of colonization ability.
Mice obtained from commercial vendors possess a variable indigenous intestinal enterococcal population ( Fig. 1e and Extended Data Fig. 3b-e ). To determine whether exogenous colonization with EF r strains replaced the indigenous enterococci to establish a stable niche in the gut, the indigenous enterococcal population was monitored after colonization with EF r or EF r 1 pPD1 (Extended Data Fig. 3b , c). EF r accounted for approximately 5-10% of the total enterococci in the faeces and declined over time to 0.1-1% ( Fig. 1e and Extended Data Fig. 3b-e ). However, EF r 1 pPD1 rapidly dominated the niche within one week and maintained this dominance over time (Extended Data Fig. 3b , c), suggesting that it was displacing or outcompeting the majority of the indigenous enterococci in the mouse gut. EF r 1 pPD1::DbacAB could not compete in the gut as it failed to displace the indigenous enterococci ( Fig. 1e and Extended Data Fig. 3b-e ). Moreover, colonization of the gut with EF r carrying another pheromone-inducible conjugative plasmid that lacks bacteriocins (pCF10) did not result in domination of the intestinal niche (Extended Data Fig. 4 ). Hence, bac-21 is likely to be responsible for the colonization advantage conferred by pPD1.
Although this result suggests that EF r 1 pPD1 directly kills competing enterococci in the gut, bac-21 might also alter physical or nutritional niches by killing other competing bacterial species 4, 19 . To investigate this, high-throughput 16S ribosomal DNA (rDNA) pyrosequencing was used to assess the composition of the gut community in colonized mice. We found no significant differences in composition between the caeca of control mice and those colonized by EF r , indicating that colonization of mice with laboratory strains of E. faecalis does not substantially alter intestinal microbial ecology (Extended Data Fig. 5a ). The caecal composition of EF r and EF r 1 pPD1 were significantly different (P 5 0.007) and clustered separately ( Fig. 1f ). However, only a member of the Gram-negative Deferribacteraceae, Mucispirillum, was significantly different between groups (Extended Data Fig. 5b ). We suggest that this may be a secondary effect, as Gram-positive bacteriocins such as bac-21 have low efficacy against Gram-negative bacteria. We conclude that elimination of competing enterococcal strains is the primary mechanism by which EF r 1 pPD1 enhances its colonization.
To further investigate bac-21-mediated enterococcal competition in the gut, a competitive colonization experiment using differentially marked E. faecalis strains was performed. Combinations of EF r and plasmid-carrying spectinomycin-resistant E. faecalis (EF s 1 pPD1) or EF r and EF s 1 pPD1 with an in-frame deletion (EF s 1 pPD1::DbacAB) were given to groups of mice, at indicated ratios ( Fig. 2 ). At week 0, faecal shedding of EF r , EF s 1 pPD1 and EF s 1 pPD1::DbacAB reflected the ratio of the bacteria given in the drinking water ( Fig. 2 ). When EF s 1 pPD1 was given in excess, it rapidly outcompeted EF r (Fig. 2g ). When EF r was given in excess ( Fig. 2a ) or equal abundance to EF s 1 pPD1 ( Fig. 2d ), it did not outcompete EF s 1 pPD1, despite being able to persist at lower levels. Subsequent experiments indicated that the ability of EF r to persist was due to conjugative transfer of pPD1 to the EF r host, thus confirming the competitive advantage conferred by bac-21. To control for unanticipated effects of the specific antibiotic resistance marker on the survival advantage of E. faecalis, the reciprocal experiment using EF s and EF r 1 pPD1 was performed and yielded similar results (Extended Data Fig. 6 ). EF s 1 pPD1::DbacAB is outcompeted by EF r in all circumstances ( Fig. 2b , e, h), confirming its loss of colonization fitness. pPD1 also provided a competitive advantage during in vitro co-culturing competitions (Extended Data Fig. 7 ). Complementation of the DbacAB strain restored bacteriocin activity, stable gut colonization (Extended Data Fig. 8 ) and the competitive advantage over other enterococci ( Fig. 2c , f, i and Extended Data Fig. 8 ).
During competition experiments, we noted the persistence of EF r when given in combination with EF s 1 pPD1. This suggested that EF s 1 pPD1 was able either to clear a niche and enhance overall EF r survival or to transfer pPD1 to EF r by conjugation. To determine whether conjugation of pPD1 occurred in the gastrointestinal tract we screened drinking water, gastrointestinal tissue (Supplementary Table 3 ) a, b, Mice were colonized by EF r (n 5 5) or EF r 1 pPD1 (n 5 6), which were enumerated weekly from faeces (a) and at week 4 from each segment of the gastrointestinal tract (b) (distal small intestine (DSI), caecum and large intestine (LI)). c, d, Mice were colonized with EF r 1 pPD1::DbacAB (n 5 5), EF r (n 5 3) or EF r 1 pPD1 (n 5 3). Faecal abundance of E. faecalis was determined weekly (c) and in the gastrointestinal tract at week 4 (d). e, Mice (n 5 5 per group) were colonized with EF r , EF r 1 pPD1, EF r 1 pPD1::DbacAB or sterile drinking water; at week 4, abundance of total enterococci (indigenous and laboratory strains) and rifampicin-resistant laboratory strains of E. faecalis was enumerated in each segment of the gastrointestinal tract. f, Microbiome analysis. Ordination of E. faecalis (n 5 5 mice) and EF r 1 pPD1 (n 5 5 mice) samples was separated by the Bray-Curtis beta diversity metric (Adonis P 5 0.007). Samples are connected to help visualize grouping. An exponential decay model was fitted to the data in a and c. In a, the rate of decay is significantly different between the two groups (P , 0.0001) and in c between EF r 1 pPD1::DbacAB and EF r (P , 0.0001), as well as between EF r 1 pPD1::DbacAB and EF r 1 pPD1 (P , 0.0001). Horizontal lines in b, d and e indicate geometric means. Each symbol represents an individual animal; data are representative of six (a, b) and two (e) biologically independent experiments. Data are from one experiment in c, d and f. Black dotted lines (all panels) indicate the limit of detection at 100 CFU per g faeces. BHI, brain-heart infusion medium; Ent, Enterococcus agar; NMDS, non-metric multidimensional scaling; ns, not significant; Rf, rifampicin. and faecal isolates ( Fig. 3a, b ) of EF r by colony polymerase chain reaction (PCR). No evidence of conjugation was observed in drinking water. The detection of transconjugants in the intestine or faeces indicated that conjugation occurred in the gastrointestinal tract. At week 1, approximately 25% of the EF r faecal colonies selected had obtained the pPD1plasmid via conjugation ( Fig. 3a, b ). By week 4, nearly 100% of the EF r colonies harboured pPD1 ( Fig. 3a , b) and produced bacteriocin (not shown). Similar results were observed in each segment of the lower gastrointestinal tract ( Supplementary Table 3 ). EF s 1 pPD1::DbacAB showed no evidence of the ability to conjugate its defective plasmid (not shown). Although complementation of bacA-E ectopically (pSK29) restored bac-21 production in EF s 1 pPD1::DbacAB, plasmid conjugation was not restored in vitro or in vivo. The mechanism underlying this observation is currently unknown.
To determine whether EF s 1 pPD1 could displace an established resident enterococcal population, we performed sequential colonization experiments, in which EF r colonization was stably established, followed by challenge with EF s 1 pPD1. The levels of EF r were not notably altered after introducing EF s 1 pPD1 (Extended Data Fig. 9 ); however, transconjugants of EF r containing pPD1 started to appear as early as week 0 and neared 100% by week 4 (Fig. 3c ). Although these results cannot distinguish extensive transfer of pPD1 by conjugation from a small number of transfer events followed by proliferation of pPD1-containing transconjugants, we conclude that pPD1 enhances E. faecalis competition in the gastrointestinal tract by bac-21-mediated killing or through transfer of a functional pPD1 plasmid via conjugation. To probe conjugation dynamics between non-isogeneic enterococci, we investigated indigenous enterococcal transconjugants in mice that were colonized with EF r 1 pPD1 ( Fig. 1e and Extended Data Fig. 3b-e ). We found that conjugation of pPD1 to indigenous enterococci is possible and can be observed both in vivo and in vitro, but also that it happens at a low and variable frequency (Extended Data Fig. 10 ). The reasons for this remain unknown, but are likely to be multifactorial, especially in the gastrointestinal tract.
Colonization with antibiotic-resistant enterococci precedes emergence of enterococcal infections. Bac-21-producing E. faecalis exhibits bacteriocin activity in vitro against many multidrug-resistant clinical isolates of E. faecium and E. faecalis ( Supplementary Table 4 ). To determine whether bac-21 can disrupt in vivo colonization by vancomycin-resistant E. faecalis V583, mice colonized with rifampicinresistant V583 (V583 r ) were challenged with the complemented bac-21 1 strain (EF s 1 pPD1::DbacAB bacA-E 1). The conjugation defect of this strain eliminated the risk for bacteriocin transfer to V583 r . EF s 1 pPD1::DbacAB bacA-E 1 successfully eliminated V583 r levels to below the detection limit in most of the mice compared to Faecal EF r colonies (100 per animal) were screened weekly for pPD1. c, Mice (n 5 5 per group) were stably colonized with EF r and then challenged with EF s 1 pPD1. Faecal EF r colonies (50 per animal) were screened weekly for pPD1. In a-c, each symbol represents the percentage of faecal transconjugants in an individual animal. The fitted logistic curve is overlain. The results in a-c are from one experiment each. LETTER RESEARCH the control group, which showed steady levels of V583 r in faeces ( Fig. 4a ). As expected, EF s 1 pPD1::DbacAB bacA-E 1 did not transfer bacteriocin to V583 r during gut colonization and the loss of pAM401::bacA-E resulted in persistent colonization by the bacteriocin-defective DbacAB strain (Fig. 4b ). V583 r clones recovered from the one mouse with persistent V583 r levels in the treated group (group 2) were examined and found to be susceptible to bac-21 in vitro. We suggest that a stochastic, particularly rapid loss of complementing plasmid (pAM401::bacA-E) from the challenging strain (EF 1 pPD1::DbacAB bacA-E 1) in that particular mouse allowed V583 r to persist over time. These results demonstrate that introducing a conjugation-defective bac-21-producing strain into the gastrointestinal tract can successfully reduce colonization by multidrugresistant E. faecalis.
Our findings provide proof of concept for a novel therapeutic strategy to specifically decolonize antibiotic-resistant enterococci from the gastrointestinal tract (of patients) and thereby prevent the emergence of resistant enterococcal infections that are otherwise difficult, or impossible, to treat. Although stable colonization by a bac-21producing E. faecalis strain (EF 1 pPD1::DbacAB bacA-E 1) can eliminate multidrug-resistant enterococci from the gut, we expect that the bacteriocin-producing strain may itself eventually acquire antibiotic resistance determinants, compromising its utility. Thus, therapeutic implementation of this strategy will probably require a modified approach. Nevertheless, use of a commensal bacterium to deliver bac-21 leverages the niche specificity of the therapeutic strain to produce bac-21 directly in the appropriate niche(s) at levels sufficient to inhibit other E. faecalis, yet not perturb the overall community. We expect that the concept presented here-specific inhibition of particular members of the gut ecosystem-will be widely applicable to modulate gut colonization by other problematic organisms as well. were colonized with V583 r . V583 r was removed from the drinking water of both groups two weeks before sampling (week -2). Group 1 received sterile water, whereas group 2 received EF s 1 pPD1::DbacAB bacA-E1 in their drinking water for two additional weeks, followed by sterile water at week 0. Faecal levels of V583 r (a) and EF s 1 pPD1::DbacAB bacA-E1 (b) were enumerated weekly. The retention of complementation plasmid pAM401A::bacA-E1 by EF s 1 pPD1::DbacAB bacA-E1 was determined weekly (b). Lines are fitted using an exponential decay model and the rate of decay is significantly different between the two groups in both a (P , 0.0001) and b (P , 0.0001). Each symbol represents an individual animal and data are representative of three biologically independent experiments. The black dotted lines indicate the limit of detection at 100 CFU per g faeces. Spc R , spectinomycin resistant; Spc R Cm R , spectinomycin resistant, chloramphenicol resistant. 
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METHODS
Bacterial strains, growth media and chemicals. The strains used in this study are listed in Supplementary Table 5 . Brain-heart infusion medium (BHI) and m-Enterococcus agar (Ent-agar) (Difco) were prepared as described by the manufacturer (Becton Dickinson). Antibiotics were purchased from Sigma and used at the following concentrations: rifampicin, 200 mg ml -1 ; spectinomycin, 500 mg ml -1 ; erythromycin, 10 mg ml -1 ; chloramphenicol, 15 mg ml -1 ; tetracycline, 10 mg ml -1 . E. faecalis was cultured in BHI media at 37 uC. All restriction enzymes were purchased from New England BioLabs. Phusion High-Fidelity DNA Polymerase (Thermo Scientific) was used for all PCRs performed for strain and plasmid construction. Oligonucleotides were synthesized by Fisher Scientific (Supplementary Table 6 ). Animals. The committee for animal care and use at the Medical College of Wisconsin approved all animal-related procedures and experiments. Five-weekold male FVB and C57Bl/6 mice were obtained from Taconic Laboratories (Oxnard and Germantown facilities). Upon arrival, mice were allowed to adapt to the new environment for at least 1 week before the start of any experiment. Animals were housed under specific-pathogen-free conditions in the Medical College of Wisconsin vivarium. Experimental sample sizes were determined by appropriate husbandry considerations as determined by the Medical College of Wisconsin vivarium and experiments were repeated as described. No blinding was performed and no scheme of randomization was applied when allocating mice for the experiments. Generation of bacAB deletion in pPD1. A mutant lacking bacAB was constructed using a marker gene (ermC) insertion in an in-frame deletion. The design for in-frame deletion and the procedure for mutant construction were similar to those used previously with pCJK218 (ref. 21) . The PCR products with the first and last codons in the bacAB fragment and flanking the ermC gene were inserted between the XbaI and SphI sites of pCJK218 by Gibson Assembly 22 to generate pSK21. Deletion mutants were isolated by plating on counter-selection medium containing 4-chloro-DL-phenylalanine followed by prolonged incubation at 30 uC (ref. 21) . The desired mutants harbouring the bacAB deletion in pPD1 plasmids (pSK35) were identified by PCR analysis and erythromycin selection. Two independent isolates were obtained and were analysed to exhibit identical phenotypes. Complementation studies. The bacABCDE fragment was amplified using primers listed in Supplementary Table 6 and was cloned into a pAM401 vector using the Gibson assembly 22 approach, resulting in pSK29. Strains with a bacAB deletion in pPD1 (CK135 pSK35 or OG1sp pSK35) were electroporated with pSK29. PCR analysis, chloramphenicol resistance and bacteriocin assay confirmed the complementation construct. Bacteriocin assays. As previously described 19 , 50 ml of an overnight culture of the indicator strain (CK135 or OG1sp) grown in BHI broth was added to 5 ml of molten BHI soft agar and then spread evenly onto a BHI agar plate. After solidification, 2 ml of the test strain that was grown overnight was spotted onto the soft agar. Zones of inhibition of the susceptible strain around the spots were monitored after overnight incubation at 37 uC. Mouse colonization model. Overnight cultures of E. faecalis were washed with sterile water and added to autoclaved water to a final concentration of 5 3 10 8 CFU ml -1 . Persistence of E. faecalis in drinking water was determined daily and remained between 10 7 and 10 8 CFU ml -1 over 3 days. Drinking water was changed every 3-4 days to maintain the appropriate inoculum and mice were allowed to drink ad libitum. After two weeks, the inoculated drinking water was replaced with sterile water for the duration of the experiment. For the sequential colonization experiment, mice were first colonized with a strain lacking pPD1 (initial strain) by feeding the bacteria through drinking water for two weeks. Three days after the initial strain was withdrawn from drinking water, the challenge strain was introduced in the drinking water for two weeks, after which animals were returned to regular sterile water (week 0). Bacterial culture and quantification of E. faecalis from mouse faeces and intestines. Faecal pellets obtained directly from living mice were weighed and homogenized in 1 ml PBS. Faecal homogenates were plated in serial dilution on BHI agar plates with appropriate antibiotics to enumerate levels of E. faecalis colonization. After mice were euthanized, the intestinal tract was removed and divided into three segments: distal 10 cm of the small intestine, caecum and large intestine. Each segment was homogenized in 2 ml PBS and cultured on BHI media with appropriate antibiotics. To enumerate indigenous enterococci or total enterococci, faecal and tissue homogenates were plated in serial dilution on Ent-agar (Difco). Alternative to BHI, laboratory strains were enumerated on Ent-agar supplemented with appropriate antibiotics. Colony PCR for bacA and bacD genes. To determine transconjugants, colonies were selected and used as PCR templates for identification of the bacA or bacD gene using gene-specific primers as described in Supplementary Table 6 . PCR products were identified using agarose gel electrophoresis. Plasmid DNA preparation and sequencing of pPD1. The pPD1 plasmid was purified as described previously 23 . Sequencing was performed at GENEWIZ, Inc.
(South Plainfield, New Jersey) on the Illumina HiSeq Platform in a 2 3 150-bp paired-end configuration. The de novo assembly using the CLC Genomics Server 6.5.1 was used to obtain assembled contigs/scaffolds. In total, 59 ORFs larger than 100 bp showing sequence similarity to known sequences in the NCBI database were identified by the NCBI ORF finder (http://www.ncbi.nlm. nih.gov/projects/gorf/). Bacterial genomic DNA extraction. Caeca were isolated from experimental animals and homogenized as described 24 29 . Abundances were recovered by mapping the demultiplexed reads to the UPARSE OTUs. A custom script constructed an OTU table from the output files generated in the two previous steps. The OTU table was used to calculate alpha and beta diversities and provide taxonomic summaries [30] [31] [32] . Bioinformatic analysis. Microbiome data were analysed using the Vegan 33 and Ecodist 34 packages in R 3.0.2 (ref. 35) . Sequence counts of each sample were normalized to the average sequencing depth, and the Bray-Curtis metric was used to assess intersample (beta) diversity. Statistical significance for differences in microbiome diversity between groups was determined using Adonis (in Vegan). NMDS ordination (in Ecodist) was used to visualize group clustering and diversity distance between samples. Log-transformed abundance data (log 10 of sequence count 1 1) was used to normalize the data and statistically significant differences in OTU abundance between groups were determined by heteroscedastic, twosided Student's t-tests. Statistical analysis of data. To compare the E. faecalis in faeces/tissues under different experimental conditions, we applied either a non-parametric Mann-Whitney-Wilcoxon or Kruskal-Wallis test owing to the skewness of the data. To model the response changes over time, we fitted an exponential decay in the following form:
where k 0 is the E. faecalis in faeces (log CFU per g) at time 0, k 1 is the rate of decay and t is time.
We also fitted a logistic curve to model the percentage transconjugants using the following equation:
where k 1 is the maximum value of the curve, k 2 is the steepness of the curve, k 3 is the time of the midpoint of the sigmoid and t is time.
For the non-linear mixed-effects models, we used a compound symmetry correlation structure to model the dependency among observations. If compound symmetry was not a good fit, a general correlation matrix or AR(1) (autocorrelation structure of order 1) correlation matrix was used. For responses that had nonzero values only at one or two time points, a model could not be fit. In these cases, we compared the responses at each time point. A linear mixed-effect model with autoregressive covariance structure was used to compare the E. faecalis in faeces over time for E. faecalis and E. faecalis 1 pPD1. Mice were treated as random. The response was log transformed and groups were compared using a two-tailed t-test at an alpha of 0.05. With 5 mice in each group, we had at least 80% power to detect a difference of at least 2.4 standard deviations. PASS 2008 was used for the calculation (http://www.ncss.com). SAS (SAS Institute, Cary, North Carolina),
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S-PLUS (Insightful Corporation, Seattle, Washington), R (ref. 35 ) and SPSS (IBM Corporation, Armonk, New York) were used for statistical analyses. All tests were two-tailed. A P-value ,0.05 was considered statistically significant. Figure 1 | EF colonization. a, C57Bl/6 mice (n 5 5) were given EF r in drinking water for 14 days. Faecal samples were taken from each animal at the transition to sterile drinking water (week 0) and then weekly. EF r abundance was determined by enumeration on brain-heart infusion (BHI) agar with rifampicin. b, V583, OG1RF and JL214 strains of E. faecalis that are rifampicin resistant were fed to groups of mice (n 5 5 per group). E. faecalis strains were enumerated weekly as described above. In both a and b, horizontal lines indicate geometric means and each symbol represents an individual animal. Data are representative of more than three experiments in a; in b, data are representative of more than three experiments for V583 r and OG1RF and the result of one experiment for JL214.
Extended Data
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Extended Data Figure 3 | pPD1 enhances E. faecalis competition for an intestinal niche. a, Bacteriocin assay by the soft agar method, with EF r 1 pPD1::DbacAB bacA-E1, EF r 1 pPD1 and EF r 1 pPD1::DbacAB spotted on a lawn of susceptible E. faecalis. Mice (n 5 5 per group) were given EF r , EF r 1 pPD1, EF r 1 pPD1::DbacAB or sterile drinking water for 14 days, after which all mice were given sterile water. b, c, One week (b) and four weeks (c) after withdrawal of E. faecalis from the drinking water, faecal samples were collected and the abundance of total enterococci was determined by enumeration on m-Enterococcus selective agar (Ent agar). Laboratory strains of E. faecalis were enumerated using Ent agar with rifampicin (Rf) or BHI agar with rifampicin. d, e, At the end of week 4, animals were euthanized and abundance of E. faecalis was determined in the distal small intestine (d) and large intestine (e) (also see Fig. 1e ). The results shown are representative of two biologically independent experiments. In b-e, horizontal lines indicate geometric means and each symbol represents an individual animal.
Extended Data Figure 4 | EF 1 pPD1 but not EF r 1 pCF10 dominates the intestinal enterococcal population. pCF10 is a well-studied pheromoneinducible conjugative plasmid of E. faecalis that encodes resistance to tetracycline but does not encode a known bacteriocin determinant. a, EF r (n 5 3 mice, no plasmid), EF r 1 pPD1 (n 5 3 mice, pPD1) or EF r 1 pCF10, (n 5 5 mice, pCF10) was added to the drinking water for 14 days and then replaced by sterile drinking water. Faecal samples were taken from each animal at the transition to sterile drinking water (week 0) and then weekly. E. faecalis abundance was determined by enumeration on BHI agar with rifampicin. An exponential decay model is used to fit the data and there are significant differences between the groups pCF10 (red) and pPD1 (blue) (P 5 0.012), as well as between the pPD1-containing and plasmid-free groups (black) (P 5 0.007). b, Four weeks after withdrawal of E. faecalis from the drinking water, animals were euthanized and abundance of EF r 1 pCF10 was determined in the distal small intestine (DSI), caecum and large intestine (LI). Mice colonized with EF r 1 pCF10 maintained long-term faecal shedding of EF r 1 pCF10 similar to EF r and persistent colonization throughout the gastrointestinal tract. c, d, Abundance of enterococci in the faeces was determined by enumeration on m-Enterococcus agar (Ent agar), Ent agar with rifampicin or BHI agar with rifampicin at week 1 (c) and week 4 (d). Unlike EF r 1 pPD1, which dominated the enterococcal niche in the gastrointestinal tract ( Fig. 1e ), EF r 1 pCF10 did not outcompete the indigenous enterococci, colonizing at levels comparable to EF r . In b-d, horizontal lines indicate geometric means and each symbol represents an individual animal; data were obtained from one experiment.
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Extended Data Figure 5 | Microbiome analysis. a, NMDS ordination of control (no EF treatment) and E. faecalis samples as separated by the Bray-Curtis beta diversity metric. Control (n 5 5 mice) and E. faecalis samples (n 5 5 mice) are intermixed. No significant difference in beta diversity was seen between the two groups. Adonis P-value 5 0.298. Samples are connected with lines to help visualize grouping. b, Analysis between E. faecalis and EF 1 pPD1 samples at the level of operational taxonomic unit suggests changes in the abundance of four bacterial genera, in particular for Deferribacteraceae;
Mucispirillum and Lachnospiraceae; Incertae sedis (P 5 0.0001 and P 5 0.005, respectively; heteroscedastic two-sided Student's t-test). Bacteria belonging to these two genera were tenfold and twofold lower, respectively, in EF 1 pPD1-colonized mice. (Note that the magnitude of change is shown in log 10 scale.) Changes in Defluviitaleaceae; Incertae sedis and Lachnospiraceae; Blautia were not as pronounced (P 5 0.03; heteroscedastic two-sided Student's t-test). However, analyses at the family taxonomy level suggest that the change in Deferribacteraceae was statistically significant.
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Extended Data Figure 6 | Reciprocal experiment for data from Fig. 2a, d and g. Groups of mice (n 5 5 mice per group) were given mixtures of EF r 1 pPD1 and EF s in drinking water at ratios of 10%/90% (a), 50%/50% (b) and 90%/10% (c), respectively. Faecal samples were obtained at the transition to sterile drinking water (week 0) and then weekly. Abundance of each E. faecalis strain in the faeces was determined by enumeration on BHI agar with rifampicin and BHI agar with spectinomycin. Abundance of EF r 1 pPD1 is indicated by open squares; abundance of EF s is indicated by open circles. Each symbol represents an individual animal. The differences between the two groups at each week were compared using a non-parametric Wilcoxon test. In a, no P-values were significant, in b, P , 0.005 and in c, P 5 0.0122 (week 0) and P 5 0.0075 (week [1] [2] [3] [4] . An exponential decay model is used for fitting the data in a and b. The results in a-c are from one experiment.
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Extended Data Figure 7 | pPD1-associated competition in vitro. Three independent cultures were carried out with various mixed populations of EF r (-) and EF s 1 pPD1 (1) or EF r (-) and EF s 1 pPD1::DbacAB (1DbacAB) in 10 ml BHI broth at ratios of 90%/10% (a, d), 50%/50% (b, e) and 10%/90% (c, f). Samples for serial dilution were taken at 0, 2, 4, 6 and 24 h after the start of the experiment. Abundance of each E. faecalis strain in faeces was determined by enumeration on BHI agar with rifampicin and BHI agar with spectinomycin. Evidence of conjugation was observed in in vitro co-cultures of a and b only by screening for transconjugants (EF r 1 pPD1) via colony PCR. Open squares represent abundance of EF s 1 pPD1 (a-c) or EF s 1 pPD1::DbacAB (d-f). Open circles represent abundance of EF r in all panels. Data are representative of two biologically independent experiments.
Extended Data Figure 8 | Complementation of bac-21 production restores colonization phenotype by providing a competitive advantage. Bacteriocin activity was restored upon ectopic expression of bacA to bacE (from pAM401) in EF 1 pPD1::DbacAB but not in E. faecalis lacking pPD1, indicating that the distal part of the bac operon (bacF to bacI) is necessary for bacteriocin expression and that the bacAB in-frame deletion is not polar on downstream genes. Mice (n 5 5) were given EF r 1 pPD1::DbacAB bacABCDE1 as described in the methods and abundance was determined by enumeration on m-Enterococcus (Ent) agar, m-Enterococcus agar plus rifampicin (Ent-Rif) or BHI agar with rifampicin (BHI-Rif). The presence of pAM401A::bacABCDE 1 (complementing plasmid) was determined by enumerating CFU on BHI agar with rifampicin and chloramphenicol (BHI-Rif Cm). Faecal samples were obtained at week 1 (a) and week 4 (b) after transition to sterile drinking water. Horizontal lines indicate geometric means. Each symbol represents an individual animal and data are representative of two biologically independent experiments. EF s 1 pPD1::DbacAB bacABCDE 1 stably colonized the gastrointestinal tract (a); however, in the absence of chloramphenicol selection, pAM401::bacABCDE was gradually lost from the population (b). Over time, loss of pAM401::bacABCDE resulted in the complemented strain reverting to the bacteriocin-defective DbacAB strain, with the loss of bacteriocin activity. Nevertheless, this strain persisted in the gut, suggesting that bac-21 was essential for clearing a niche for E. faecalis; once cleared, E. faecalis uses other mechanisms to maintain colonization.
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G2015 Macmillan Publishers Limited. All rights reserved Extended Data Figure 9 | EF r levels are not altered by sequential colonization with EF s 1 pPD1. Groups of mice (n 5 5 mice per group) were given EF r in drinking water for two weeks and subsequently challenged with EF s 1 pPD1 in drinking water for another two weeks (starting from week -2) before transition to sterile water (week 0). Faecal samples were obtained weekly to enumerate the abundance of EF r (a) and EF s 1 pPD1 (b) on BHI agar with rifampicin and spectinomycin, respectively. Each symbol represents an individual animal and data are from one experiment.
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Extended Data Figure 10 | Conjugation frequency of pPD1 between the laboratory strain (EF 1 pPD1) and indigenous enterococci in vitro. To understand conjugation dynamics between non-isogeneic species of enterococci, we investigated indigenous enterococcal transconjugants in mice that were colonized with EF r 1 pPD1 ( Fig. 1e and Extended Data Fig. 3b-e ). However, we were unable to detect rifampicin-sensitive enterococci from the faecal sample at week 4 (Extended Data Fig. 3c ). At week 1, only nine clones of rifampicin-sensitive enterococci (out of 730 enterococci) were isolated from three mice in a group of five (Extended Data Fig. 3b ). Bacteriocin assays and probing for the bacA gene sequence confirmed that six of the nine clones were transconjugants and were bac-21 positive. 16S rDNA gene sequencing of these nine clones showed notable similarities to E. faecalis 16S rDNA. To understand the reason for the low conjugation frequency between indigenous enterococci and the laboratory strain of EF r 1 pPD1, in vitro conjugation experiments were performed to assess the frequency of plasmid transfer. Ten new clones of indigenous enterococci were isolated from the faeces of five mice (two clones per mouse that were not colonized with any laboratory strain) by culturing on m-Enterococcus agar. EF r 1 pPD1 was mixed with each of the ten indigenous enterococci clones in BHI broth at a ratio of 1:9. Samples for serial dilution were taken at the start of the culture (a) and 24 h after the start of the experiment (b). Abundance of total enterococci was determined using m-Enterococcus agar and BHI agar with rifampicin for EF r 1 pPD1. Data are representative of three biologically independent experiments. In vitro bacteriocin assays revealed that EF r 1 pPD1 is capable of killing most of the non-pPD1-containing indigenous enterococci strains (not shown). In vitro conjugation assays between individual indigenous enterococci clones and EF r 1 pPD1 led to three observations: first, 4 out of 10 clones were susceptible to bac-21 and were eliminated by EF r 1 pPD1 (no. 3, 4, 8 and 9); second, 6 out of 10 were immune to bac-21 killing (no. 1, 2, 5, 6, 7 and 10); third, probing for bacA provided evidence for pPD1-containing indigenous enterococci transconjugants in 4 out of the 6 immune indigenous enterococci clones. The two clones that failed to conjugate and were resistant to bac-21 killing in the mixed culture experiment were also resistant to EF r 1 pPD1 on bacteriocin assay plates. The mechanism for resistance of these two clones is not clear; however, they might have harboured cross-resistance traits. Error bars represent s.e.m.
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